| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-09 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-08 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.23 | 7e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |